109354 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines Tumour necrosing factors [TNF]
METHOD FOR GENERATING NK CELLS
#2METHOD FOR PRODUCING LOW-ANTIGENIC CELL
#3T CELL PRODUCTION METHOD
#4ACTIVATION AND PROLIFERATION OF CYTOTOXIC LYMPHOCYTES
#5MESENCHYMAL PROGENITOR CELLS FOR ENHANCING PARTIAL REPROGRAMMING OF TARGET CELLS
#6SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION
#7CELL SYSTEM AND APPLICATION THEREOF, AND METHOD FOR ACTIVATING BROAD-SPECTRUM CANCER CELL-SPECIFIC T CELL
#8METHOD FOR PRODUCING MATURE DENDRITIC CELLS
#9METHODS OF GENERATING T-CELLS FROM STEM CELLS AND IMMUNOTHERAPEUTIC METHODS USING THE T-CELLS
#10SIRPa DEFICIENT MACROPHAGES FOR TREATING CANCER
#11Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#12CANCER-KILLING CELLS
#13BIOMATERIALS FOR IMPROVING BRAIN HEALING AFTER STROKE AND METHODS OF USING SAME
#14METHOD FOR MAINTAINING SUPPRESSIVE ACTIVITY OF REGULATORY T CELLS
#15CD83+, CD83+PD-L1+ MESENCHYMAL STEM CELLS AND PREPARATION METHODS AND USE THEREOF
#16REGULATORY T CELL STABILITY ASSAY
#17COMBINATION THERAPY COMPRISING PD-L1 KNOCKOUT NK CELL AND ANTI-PDL1 ANTIBODIES
#18IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE
#19METHOD FOR PRODUCING REGULATORY T CELLS
#20METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN
#21CELLULAR MICROCOMPARTMENTS COMPRISING LYMPHOCYTES FORMING A GROUPED 3D CULTURE AND HAVING A LOW TNF ALPHA CONTENT
#22COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#23COMPOSITIONS AND METHODS FOR ACTIVATING IMMUNE CELLS
#24T CELL MANUFACTURING COMPOSITIONS AND METHODS
#25OSTEOPOROSIS MODEL COMPRISING CALCIUM PHOSPHATE HYDROGEL COMPOSITION AND USE THEREOF
#26STABLE REGULATORY T CELLS AND METHODS OF PRODUCTION
#27CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#28METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES
#29Compositions And Methods For Making And Using Atherosclerotic Nanomatrix Vascular Sheets
#30METHOD FOR CULTURING NATURAL KILLER CELL, USING TRANSFORMED T CELL
#31CULTURE MEDIUM AND CULTURE METHOD FOR MAMMARY EPITHELIAL CELLS, AND USE OF MAMMARY EPITHELIAL CELLS
#32METHODS FOR INCREASING VIRAL TRANSDUCTION OF CELLS
#33Systems and Methods Incorporating Modified T-Cells
#34NATURAL KILLER CELLS AND CD123 NK CELL ENGAGER COMBINATION THERAPY
#35METHOD FOR PRODUCING MACROPHAGES, DIFFERENTIATION INDUCING AGENT, DIFFERENTIATION INDUCTION KIT, METHOD FOR CULTURING MACROPHAGES, AGENT FOR PROMOTING MACROPHAGE PROPAGATION, KIT FOR PROMOTING MACROPHAGE PROLIFERATION, METHOD FOR MACROPHAGE PROLIFERATION, AND MACROPHAGES
#36NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF
#37EXTRACELLULAR VESICLE THERAPY TO TREAT ORTHOPEDIC INJURY
#38REGULATORY T CELLS TARGETED BY LYMPHOTOXIN ALPHA BLOCKING AGENT AND USES THEREOF
#39TRANSGENIC T CELL RECEPTORS TARGETING NEOANTIGENS FOR DIAGNOSIS, PREVENTION, AND/OR TREATMENT OF HEMATOLOGICAL CANCERS
#40Methods for Screening B Cell Lymphocytes
#41Creation of Inducible Pluripotent Stem Cell Derived T Regulatory Cells by In Vitro Recapitulation ofThymic Development
#42TREATMENT OF CANCER WITH NK CELLS AND MULTISPECIFIC ENGAGERS
#43METHOD FOR PRODUCING T CELL
#44Methods of T Cell Expansion and Activation
#45COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME
#46COMPOSITIONS AND METHODS FOR PROTECTING ANIMAL CELLS FROM COMPRESSIVE FORCES
#47METHODS AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES
#48BIOCOMPATIBLE CONDITIONED CELL MEDIUM COMPOSITIONS AND USES THEREOF
#49MonoMac-1 Cells Expressing CD16 and CD163
#50Composition and Method for Treating Diseases Thereof
#51PHYSIOLOGY AND PATHOPHYSIOLOGY OF HUMAN GUT: INTESTINE-ON-CHIP
#52MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#53CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS
#54COMBINED ADMINISTRATION COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS, COMPRISING FUNCTION-ENHANCED STEM CELLS AND REGULATORY T CELLS
#55METHODS FOR INDUCING AN IMMUNE RESPONSE BY ADMINISTERING ACTIVATED MESENCHYMAL STEM CELLS
#56METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
#57SYSTEMS AND METHODS FOR GROWTH OF INTESTINAL CELLS IN MICROFLUIDIC DEVICES
#58GENERATING T CELL PRECURSORS VIA AGONIZING TUMOR NECROSIS FACTOR RECEPTOR 2
#59PREVENTIVE AND/OR THERAPEUTIC AGENT FOR PRESSURE ULCER
#60METHOD FOR GENERATING PROGENITOR T CELLS FROM STEM AND/OR PROGENITOR CELLS AND USE OF SAME
#61METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS
#62CANCER-KILLING CELLS
#63METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#64PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC LINEAGES
#65STING DEPENDENT ADJUVANTS
#66TISSUE-SPECIFIC ANTIGENS FOR CANCER IMMUNOTHERAPY
#67METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#68RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH CD14 PROMOTER AND USE THEREOF
#69RHEOLOGICALLY BIOMIMETIC FLUID SURROGATE
#70METHOD FOR T-CELL EXPANSION AND RELATED MEDICAL APPLICATIONS
#71EXPANDED AND STIMULATED NATURAL KILLER CELLS
#72STEM CELL PRIMING COMPOSITION AND PRIMED STEM CELL
#73NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF
#74IPSC-DERIVED ASTROCYTES AND METHODS OF USE THEREOF
#75B-CELL CULTIVATION METHOD
#76METHODS, COMPOSITIONS, AND KITS FOR EXPANDING NATURAL KILLER CELLS
#77RAS NEOANTIGENS AND USES THEREOF
#78Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#79CANCER-KILLING CELLS
#80METHOD FOR GENERATING T CELLS PROGENITORS
#81Exosome for stimulating T cell and pharmaceutical use thereof
#82PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE
#83COMPOSITIONS AND METHODS OF GENERATING AN IMMUNE RESPONSE
#84LARGE-SCALE PRODUCTION OF EXOSOMES FROM PRIMED MESENCHYMAL STROMAL CELLS FOR CLINICAL USE
#85Physiology and pathophysiology of human gut: intestine-on-chip
#86Method for inhibiting growth of cancer cells using anti-cancer composition with mesenchymal stem cells conditioned medium
#87Decidual placental mesenchymal stem cell and the use of the cell for preparing pharmaceutical compositions for promoting angiogenesis
#88METHODS FOR RAPID CLONING AND EXPRESSION OF HLA CLASS I CELLS
#89METHOD OF PRODUCING TUMOR-REACTIVE T CELL COMPOSITION USING MODULATORY AGENTS
#90MEDIA FORMULATIONS AND METHODS FOR PRODUCING PROGENITOR T CELLS
#91PRIMING MEDIA AND METHODS FOR STEM CELL CULTURE AND THERAPY
#92Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
#93Biocompatible conditioned cell medium compositions and uses thereof
#94Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#95Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#96Systems and methods for growth of intestinal cells in microfluidic devices
#97ANTIBODY PRODUCING MICROFLUIDIC DEVICES
#98Systems for producing cellular immunotherapeutics and methods of use thereof
#99CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#100METHODS FOR DETERMINING RISK OF DEVELOPING INSULIN RESISTANCE
#101HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#102Regulatory T cells targeted by lymphotoxin alpha blocking agent and uses thereof
#103COMPOSITIONS AND METHODS FOR DETECTING HIV LATENCY, TREATING HIV INFECTION, AND REVERSING HIV LATENCY
#104ENGINEERED GAMMA DELTA T CELLS AND METHODS OF MAKING AND USING THEREOF
#105BEAD-FREE EX-VIVO EXPANSION OF HUMAN REGULATORY T CELLS
#106EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS
#107METHOD FOR PREPARATION OF CANCER/TESTIS ANTIGEN-SPECIFIC T-CELLS
#108CRYOPRESERVATION AND CELL CULTURE MEDIA
#109Methods of treating cancers with CT45 targeted therapies
#110Osteoporosis model comprising calcium phosphate hydrogel composition and use thereof
#111NOVEL EXOSOME PRODUCTION METHOD AND APPLICATION THEREOF
#112Recombinant adeno-associated virus vectors with CD14 promoter and use thereof
#113Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells
#114Material and method for storing, transferring and delivering mesenchymal stem cells which are immediately available and functional in the context of a myocardial infarction
#115IN VITRO MODEL OF LIVER STEATOSIS AND FIBROSING NON-ALCOHOLIC STEATOHEPATITIS
#116CELL COMPOSITION COMPRISING LIVER PROGENITOR CELLS EXPRESSING HLA-E
#117FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#118Methods and reagents for modulating macrophage phenotype
#119CONSTITUTIVE EXPRESSION OF COSTIMULATORY LIGANDS ON ADOPTIVELY TRANSFERRED T LYMPHOCYTES
#120METHODS AND APPARATUS FOR CONDITIONING CELL POPULATIONS FOR CELL THERAPIES
#121NOVEL C-MET AND TMX2 ANTIBODIES
#122Compositions and methods for immune cell modulation in adoptive immunotherapies
#123Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#124FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#125THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
#126Cellular Targeted Label Delivery System
#127METHODS, KITS AND COMPOSITIONS FOR CHARACTERIZING AN ANTI-INFLAMMATORY RESPONSE OF A PRODUCT
#128METHOD FOR PRODUCING CD3-POSITIVE CELL
#129Mycobacterial antigen compositions and methods of use
#130Engineered Exosomes for Medical Applications
#131METHOD FOR PRODUCING FIBROBLAST, AND G-CSF-POSITIVE FIBROBLAST MASS
#132ALLOGENEIC TUMOR CELL VACCINE
#133Methods for inducing an immune response by administering activated mesenchymal stem cells
#134UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF
#135Development of dual whole cell-based vaccine against pancreatic cancer
#136METHOD OF INDUCING DEDIFFERENTIATION OF SOMATIC CELLS WITH SMALL MOLECULES TO PREPARE REJUVENATED MESENCHYMAL STEM CELLS AND USES THEREOF
#137Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression
#138Cancer-killing cells
#139Mesenchymal stem cells expressing TNF-α receptors
#140METHOD FOR THE TREATMENT OF A TUMOR PATIENT WITH ADOPTIVE T CELL IMMUNOTHERAPY
#141Method for generating T cell progenitors
#142Method for generating T cells progenitors
#143METHODS FOR EXP ANDING ADIPOSE-DERIVED STEM CELLS
#144METHOD FOR LARGE-SCALE PRODUCTION OF HUMAN ALLOSPECIFIC INDUCED-REGULATORY T CELLS WITH FUNCTIONAL STABILITY IN THE PRESENCE OF PRO-INFLAMMATORY CYTOKINES WITH THERAPEUTIC POTENTIAL IN TRANSPLANTATION
#145B-CELL CULTIVATION METHOD
#146METHODS FOR EXPANDING ADHERENT STROMAL CELLS AND CELLS OBTAINED THEREBY
#147METHOD FOR PRODUCING HUMAN A1 ASTROCYTES, HUMAN A1 ASTROCYTES, AND METHOD FOR EVALUATING TEST SUBSTANCE
#148SINGLE B-CELL CULTIVATION METHOD
#149Exosome active formulation for inhibiting endothelial cell migration, and preparation method and application
#150MEDICAL USES OF EXOSOMES
#151Methods for directed differentiation of pluripotent stem cells to immune cells
#152Method for activating T cells for cancer treatment
#153METHOD FOR PRODUCING LOW-ANTIGENIC CELL
#154B-cell cultivation method
#155Method for generating T cells progenitors
#156RAPID METHOD FOR THE CULTURE OF TUMOR INFILTRATING LYMPHOCYTES
#157Methods for expansion or depletion of T-regulatory cells
#158STEM CELL MATERIAL AND METHOD OF MANUFACTURING
#159MEDICINE FOR TISSUE REGENERATION, AND PREPARATION METHOD THEREFOR
#160Rheologically biomimetic fluid surrogate
#161Method for activating T cells for cancer treatment
#162Methods of preparing hematopoietic progenitor cells in vitro
#163Methods and apparatus for conditioning cell populations for cell therapies
#164Methods of T cell expansion and activation
#165B-cell cultivation method
#166Method of autologous primary hair follicles preparation in 3D culture
#167Altered adherent stromal cells and methods of producing and using same
#168Method of preparing in vitro-matured human intestinal organoids and use thereof
#169Method for culturing natural killer cell, using transformed T cell
#170Genomic engineering of pluripotent cells
#171Biocompatible conditioned cell medium compositions and uses thereof
#172Exosome for stimulating T cell and pharmaceutical use thereof
#173Method for producing B cell population and method for producing monoclonal antibody using same
#174METHODS FOR SCREENING B CELL LYMPHOCYTES
#175METHOD FOR GENERATING T CELLS PROGENITORS
#176Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
#177Cellular targeted active ingredient delivery system
#178MonoMac-1 cells expressing CD16 and CD163
#179Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
#180STEM CELL MICROPARTICLES AND miRNA
#181METHODS OF GENERATING OLIGODENDROCYTES AND CELL POPULATIONS COMPRISING SAME
#182Anti-cancer T cells and their preparation using coenzyme A
#183Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#184CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#185Cancer-killing cells
#186Methods and reagents for modulating macrophage phenotype
#187Cancer vaccines and vaccination methods
#188Genomic engineering of pluripotent cells
#189METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS
#190Methods for generating functional therapeutic B cells ex-vivo
#191Non-cytotoxic modified cells and use thereof
#192Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
#193Generation of HPV-specific T-cells
#194METHOD FOR MEASURING IMMUNOGENICITY OF PROTEIN AGENT
#195Systems and methods for growth of intestinal cells in microfluidic devices
#196Methods of treating cancers with CT45 targeted therapies
#197Method for generating progenitor t cells from stem and/or progenitor cells and use of same
#198Technique for Enhancing Stem Cell Regeneration Through Interaction of Vascular Endothelial Cell and Mesenchymal Stem Cell
#199Compositions and methods for immune cell modulation in adoptive immunotherapies
#200Development of dual whole cell-based vaccine against pancreatic cancer
#201Methods of producing activated mesenchymal stem cells
#202Systems and methods for growth of intestinal cells in microfluidic devices
#203Individualized Immunomodulation Therapy for Neurodegenerative Disorders, CNS Injury and Age-Related Dementia
#204Pharmaceutical composition for preventing or treating regulatory T cell-mediated diseases
#205B-cell cultivation method
#206Recombinant production method
#207Induction medium and methods for stem cell culture and therapy
#208Therapeutic cancer vaccines derived from a novel dendritic cell line
#209Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#210Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#211Methods for propagating mesenchymal stem cells (MSC) for use in transplantation
#212Methods for directed differentiation of pluripotent stem cells to immune cells
#213SINGLE B-CELL CULTIVATION METHOD
#214ANGIOGENESIS USING STIMULATED PLACENTAL STEM CELLS
#215SYSTEM FOR IMMUNOTHERAPY TARGETING TUMOR PROPAGATION AND PROGRESSION
#216Systems for producing cellular immunotherapeutics and methods of use thereof
#217Generation of HPV-specific T-cells
#218DEVICES AND METHODS FOR SELECTING APOPTOSIS-SIGNALING RESISTANT CELLS, AND USES THEREOF
#219Methods and apparatus for conditioning cell populations for cell therapies
#220Allogeneic tumor cell vaccine
#221Growth and survival compositions for cells capable of producing antibodies and methods related thereto
#222Methods for expansion or depletion of t-regulatory cells
#223Therapy and methods for introducing immature and dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
#224Genomic engineering of pluripotent cells
#225Enrichment of CD16+ monocytes to improve dendritic cell vaccine quality
#226Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#227Methods of generating oligodendrocytes and cell populations comprising same
#228MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#229Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#230DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME
#231Stem cell material and method of manufacturing
#232EX VIVO DEVELOPMENT, EXPANSION AND IN VIVO ANALYSIS OF A NOVEL LINEAGE OF DENDRITIC CELLS
#233Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same
#234Method for preparing dendritic cell, dendritic cell prepared thereby, and use thereof
#235POLYVALENT ANTI-TUMOR FIBROBLAST VACCINE
#236Cancer vaccines and vaccination methods
#237Composition including Stem Cell-Derived Exosome for Inducing Adipogenic Differentiation and Adipose Tissue Regeneration
#238Culture medium for cellular immunotherapy
#239Multi-lineage hematopoietic precursor cell production by genetic programming
#240Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
#241COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS
#242Method for proliferation of antigen-specific T cells
#243METHODS FOR TESTING T CELL PRIMING EFFICACY IN A SUBJECT
#244Galactose oxidase treatment of dendritic cells to improve their immunogenicity
#245Methods and compositions related to T-1 dendritic cells
#246ACTIVATION OF HEMATOPOIETIC PROGENITORS BY PRETRANSPLANT EXPOSURE TO DEATH LIGANDS
#247Stem cell microparticles and miRNA
#248Composition of stem cells having highly expressed FAS ligand
#249Induction medium and methods for stem cell culture and therapy
#250Muscle stem cell in vitro culture method and application
#251System for immunotherapy targeting tumor propagation and progression
#252Induction medium and methods for stem cell culture and therapy
#253Tolerogenic dendritic cells for treating myocardial infarction and manufacturing method thereof
#254Methods for stimulating antigen-specific T cell responses
#255Cancer vaccines and vaccination methods
#256Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#257Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#258Methods for expansion or depletion of T-regulatory cells
#259T cell balance gene expression, compositions of matters and methods of use thereof
#260Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use
#261OVARIAN CANCER VACCINES AND VACCINATION METHODS
#262Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
#263RNA preparations comprising purified modified RNA for reprogramming cells
#264Compositions for inducing or suppressing an immune response
#265GROWTH FACTOR COCKTAIL TO ENHANCE OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL CELLS
#266Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#267Therapeutic cancer vaccines derived from a novel dendritic cell line
#268Method for obtaining monocytes or NK cells
#269METHOD FOR LOADING OF DENDRITIC CELLS WITH CLASS I ANTIGENS
#270STEM CELL MICROPARTICLES
#271METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#272Dendritic Cell Compositions and Methods
#273Composition for maturing dendritic cells, and method for preparing antigen-specific dendritic cells using same
#274METHOD FOR EX-VIVO PURGING IN AUTOLOGOUS TRANSPLANTATION
#275Therapy and methods of introducing immature dendritic cells and/or cytotoxic T lymphocyte and anti-TNF antibody for treatment of tumors
#276Method of increasing proliferation of bone marrow mononuclear cells expressing STRO1-
#277Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof
#278Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#279Compositions for the preparation of mature dendritic cells
#280Methods and composition related to Th-1 dendritic cells
#281Method for attenuating immune response using mesenchymal stem cells and cytokines
#282Method for proliferation of antigen-specific T cells
#283Tissue-engineered endothelial and epithelial implants repair multilaminate tubular airway structure
#284Ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
#285Dendritic cells obtained from induced pluripotent stem cells (iPSCs)
#286Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor
#287Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
#288System for immunotherapy targeting tumor propagation and progression
#289Compositions and methods for producing dendritic cells
#290Cancer vaccines and vaccination methods
#291Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
#292Tissue-Engineered Endothelial and Epithelial Implants Differentially and Synergistically Regulate Tissue Repair
#293METHOD FOR PREPARING REGULATORY DENDRITIC CELLS
#294VACCINES WITH ONCOFETAL ANTIGEN/ILRP-LOADED AUTOLOGOUS DENDRITIC CELLS AND USES THEREOF
#295Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
#296MUTZ-3 dendritic cells
#297Cryoconserved mature dendritic cells
#298Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation
#299Mesenchymal stem cells expressing TNF-alpha receptors
#300Cancer vaccines and vaccination methods